Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radiation Therapy in Journal of Drugs in Dermatology
Sensus Healthcare, Inc. (SRTS)
Last sensus healthcare, inc. earnings: 2/13 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
sensushealthcare.appcodes.io
Company Research
Source: GlobeNewswire
Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT BOCA RATON, Fla. , March 03, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced that results from a retrospective study of non-melanoma skin cancer (NMSC) patients treated with superficial radiation therapy (SRT) were published in the February 2020 issue of Journal of Drugs in Dermatology. The study showed a non-recurrence rate of 98.9% after 85 months in 516 patients with a total of 776 NMSC lesions treated with SRT. Patients were treated with the SRT-100™ system marketed by Sensus Healthcare at four clinical sites prior to January 2015. The article, “Long-Term Efficacy and Safety of Superficial Radiation Therapy in Subjects With Nonmelanoma Skin
Show less
Read more
Impact Snapshot
Event Time:
SRTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRTS alerts
High impacting Sensus Healthcare, Inc. news events
Weekly update
A roundup of the hottest topics
SRTS
News
- What Makes Sensus Healthcare (SRTS) a Good Fit for 'Trend Investing' [Yahoo! Finance]Yahoo! Finance
- Sensus Healthcare, Inc. (NASDAQ: SRTS) had its price target raised by analysts at HC Wainwright from $10.00 to $11.00. They now have a "buy" rating on the stock.MarketBeat
- REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third QuarterGlobeNewswire
- Sensus Healthcare, Inc. (NASDAQ: SRTS) had its price target raised by analysts at Maxim Group from $12.00 to $14.00. They now have a "buy" rating on the stock.MarketBeat
- Sensus Healthcare Inc (SRTS) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... [Yahoo! Finance]Yahoo! Finance
SRTS
Earnings
- 11/14/24 - Beat
SRTS
Analyst Actions
- 11/15/24 - Maxim Group
SRTS
Sec Filings
- 11/18/24 - Form 8-K
- 11/14/24 - Form 10-Q
- 11/14/24 - Form 8-K
- SRTS's page on the SEC website